
Taking part in the congress, organised by the Portuguese Association of Anatomical Pathology Technicians (APTAP), was an opportunity to present technological solutions and strengthen relationships with professionals and partners in the sector.
Quilaban attended the 26th Technical Anatomy Congress, organised by the Portuguese Association of Anatomical Pathology Technicians (APTAP), which took place from 8 to 10 October in Oeiras. The event brought together professionals from the sector and provided an opportunity to share knowledge, present technological innovations and keep up with developments in Anatomical Pathology and Precision Medicine in Portugal.
Over the three days, Quilaban’s Clinical and Genomic Diagnostics teams showcased technologies from its partnerships with Illumina, Pillar Biosciences, QIAGEN and Molbio. The solutions presented covered areas such as Next-Generation Sequencing (NGS), digital Polymerase Chain Reaction (PCR) and Digital Pathology, highlighting their potential to support the evolution of diagnostic processes.
In collaboration with Illumina, Quilaban also hosted a session entitled “Enhancing Precision Oncology: Transitioning to NGS”, featuring Dr Antònia Obrador Hévia. The specialist shared her experience of implementing NGS technology in her laboratory in Majorca, exploring how this approach contributes to the advanced detection of biomarkers and the personalisation of treatment decisions in oncology.
Beyond the presentation of technologies, the congress offered opportunities to meet industry professionals, exchange experiences and keep up with scientific advances in the field of diagnostics.
The scientific quality of the event, the organisation and the collaborative atmosphere fostered by APTAP contributed to the success of this edition. Quilaban’s participation was also marked by close contact with clients, partners and professionals who visited the stand, in a space for dialogue about the challenges and the future of Anatomical Pathology.
This presence reflects Quilaban’s commitment to keeping pace with scientific and technological developments, contributing to the creation of solutions that support increasingly precise and personalised diagnosis.